Camp4 Therapeutics (CAMP) Non-Current Assets (2023 - 2026)

Camp4 Therapeutics recorded quarterly Non-Current Assets of $3.3 million in Q1 2026, down 12.2% quarter-over-quarter from $3.7 million in Q4 2025, and down 70.63% year-over-year from $11.1 million in Q1 2025.

Camp4 Therapeutics' Non-Current Assets history runs 4 years deep, the most recent figure standing at $3.3 million for Q1 2026.

  • In Q1 2026, Non-Current Assets fell 70.63% year-over-year to $3.3 million; the TTM figure through Mar 2026 stood at $25.8 million (down 51.97% YoY), while the FY2025 annual figure was $3.7 million, down 68.86% from the prior year.
  • Non-Current Assets came in at $3.3 million for Q1 2026 at Camp4 Therapeutics, down from $3.7 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $15.9 million in Q3 2024 to a low of $3.3 million in Q1 2026.
  • A 4-year average of $10.0 million and a median of $10.6 million in 2025 frame the typical range for Non-Current Assets.
  • Across the five-year window, Non-Current Assets decreased 20.15% in 2024 and tumbled 70.63% in 2026, its largest moves.
  • Camp4 Therapeutics' Non-Current Assets stood at $14.9 million in 2023, then fell by 20.15% to $11.9 million in 2024, then plunged by 68.86% to $3.7 million in 2025, then slipped by 12.2% to $3.3 million in 2026.
  • According to Business Quant data, Non-Current Assets over the past three periods registered $3.3 million, $3.7 million, and $8.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 4.56 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 62,953.78
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 486.60 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 5.83 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 30.30 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 14.75 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 22.66 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 910.24 Mn
10 Camp4 Therapeutics 245.89 Mn 245.89 Mn - 3.26 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 3.26 Mn
Dec 31, 2025 3.71 Mn
Sep 30, 2025 8.69 Mn
Jun 30, 2025 10.19 Mn
Mar 31, 2025 11.10 Mn
Dec 31, 2024 11.92 Mn
Sep 30, 2024 15.86 Mn
Dec 31, 2023 14.93 Mn